2016 Review - Page 1 | TalkMarkets
All Posts > Content under 2016 Review
1 to 16 of 54 Posts
1 2 3 4
Biotech Sector Leads Market Early In 2017 Despite Uncertainties
Article By: Rod Raynovich
Sunday, April 16, 2017 2:14 AM EDT
Despite recent weakness over the past month the biotech sector has continued to outperform the market. Healthcare is up 7.3% and biotech stocks lead or match performance of the strong technology sector up 11% YTD.
In this article: XBI Also: FBIOX, IBB, FBT, INCY, SGEN, VRTX, ALKS, EXEL
Read
Wells Just Reported The Worst Mortgage Number Since The Financial Crisis
Article By: Tyler Durden
Thursday, April 13, 2017 8:57 AM EDT
In Q1 the amount of all-important Mortgage Applications has tumbled by a whopping 23% to just $59 billion, below the lows hit in early 2014, and at fresh lows since the financial crisis.
In this article: WFC
Read
Chemical Industry Back On Track: Stocks Worth A Look
Article By: Zacks Investment Research
Monday, April 3, 2017 7:00 AM EDT
The U.S. chemical industry is expected to be one of the key beneficiaries of Trump's presidency. Chemical stocks got a boost following Trump’s election win in November on expectations of significant infrastructure spending in a Trump administration.
In this article: KMG, ALB, DD, DOW, KRO, MON, SYT, UNVR, CC
Read
Best And Worst Performing EM ETFs Of This Year
Article By: Zacks Investment Research
Sunday, April 2, 2017 8:28 AM EDT
The Emerging Market ETFs corner has been a revelation in 2017. Despite concerns over the “Trump Effect” on emerging market economies, the MSCI Emerging Markets Index is up more than 12% on a year-to-date basis.
In this article: ERUS, EMQQ, NGE, PAK, SCIN, GHE
Read
Will Healthcare And Biotech Resume Market Leadership?
Article By: Justin Smyth
Wednesday, March 29, 2017 5:37 AM EDT
Biotech ETFs XBI and IBB are outperforming so far this year. It’s not too surprising if you use Stage Analysis since we know that bear markets are authors of bull markets, and biotech was one of the worst performing sectors of 2016.
In this article: IBB, XBI, XLV Also: IHI
Read
A Most Wonderful Year For Small-Caps
Article By: ValueWalk
Sunday, March 12, 2017 2:48 PM EDT
By any measure, 2016 was a terrific year for small-cap stocks, one that featured a double-digit positive return for the Russell 2000 Index, which advanced 21.3%, and a solid advantage over their large-cap counterparts.
In this article: IWM
Read
Buffett Stocks In Focus: U.S. Bancorp
Article By: SureDividend
Sunday, March 5, 2017 3:23 PM EDT
Bancorp ended 2016 with $446 billion in assets, making it the-fifth largest commercial bank in the country. It has more than 3,100 banking offices and more than 4,000 ATMs.
In this article: USB, BRK-A
Read
Berkshire Letter Highlights: Buffett Slams Hedge Funds, Likes Immigrants And The US Outlook
Article By: Tyler Durden
Sunday, February 26, 2017 3:14 AM EDT
Berkshire Hathaway's Q4 profit rose 15% as net income increased to $6.29 billion, while operating earnings, which exclude some investment results, were $2,665 a share, a slight miss to the $2,717 consensus estimate.
In this article: BRK-A, BRK-B Also: DOW, VRX, AAPL, SPY
Read
E Biotechnology: Poised To Head Higher
Article By: Tarun Chandra, CFA
Sunday, February 19, 2017 3:23 AM EDT
Biotechnology sector has struggled to overcome regulatory uncertainty. We believe now there is sufficient momentum for Biotechs to breakout and record new 52-week highs compared to a -21% decline in 2016.
In this article: JNJ, LLY, SGYP, ACAD, ARIA, IBB, INCY, IWM, XBI, PTLA
Read
Large Cap Biopharmaceuticals: Update On Financial Metrics
Article By: Rod Raynovich
Sunday, February 12, 2017 4:12 AM EDT
We have updated the comparison of eight large cap biopharma stocks post 2016 earnings for the period ending 2/10/17. Keep in mind that in January 2016 there was a severe correction with stocks dropping 25-30% with lows being hit in February 2016.
In this article: BMY, ALXN, AMGN, CELG, GILD, ABBV, IBB, REGN Also: XBI
Read
E U.S. Weekly Stock Market Valuation Indicator: Near Record Highs
Article By: Atle Willems
Saturday, February 11, 2017 3:05 PM EDT
The weekly stock market valuation indicator, comparing a broad U.S. stock market index with the money supply a leading economic indicator, increased slightly compared to last week.
Read
The Cycle Reduces, And Starts All Over Again
Article By: Jeffrey P. Snider
Saturday, January 28, 2017 1:16 PM EDT
Year-over-year, NRFI was up just 0.3%, but that was the first positive comparison since Q4 2015. More importantly, however, total GDP capex is just barely more than it was in Q3 2014 and in no hurry, again, to resume forward momentum.
Read
2016 GDP Slowest Growth In 5 Years: Many Troubling Items; Three Hikes Really?
Article By: Mish Shedlock
Friday, January 27, 2017 3:15 PM EDT
With GDP at 1.6% for the full year, really think the Fed will hike thrice? Global exports have collapsed. And we have not yet seen the effects of Trump’s seriously misguided protectionist trade policy.
Read
E Fresnillo Plc. Delivers Record Production Figures
Article By: Simple Digressions
Thursday, January 26, 2017 3:00 PM EDT
Fresnillo plc., in 2016 the company extracted 45.7 million ounces of silver (an increase of 6.2%, compared to 2015). Gold production went up from 762 thousand ounces in 2015 to 936 thousand ounces last year (an increase of 22.8%).
In this article: FNLPF Also: ABX, GG, NEM
Read
China Enjoys Robust Growth
Article By: Mike Campbell
Thursday, January 26, 2017 5:36 AM EDT
At the end of a turbulent year, China has posted some highly encouraging growth figures which suggest that the economy grew at a rate of 6.7% for 2016 over the 2015 benchmark.
In this article: GXC
Read
2016 Recap: The "Austrian" True Money Supply For The U.S.
Article By: Atle Willems
Wednesday, January 25, 2017 1:15 PM EDT
How to compile an accurate money supply and how the money supply has evolved during the last few decades?
Read
1 to 16 of 54 Posts
1 2 3 4